Skip to main content
. 2026 Mar 27;27(7):3074. doi: 10.3390/ijms27073074
Honey Type of Cancer Cells Findings In Vitro/In Vivo/Clinical Trial References
Acacia Lung cancer cell (NCI-H460) Inhibited cell proliferation via cell cycle arrest at G0/G1 phase, stimulation of cytokines and calcium ion, and downregulation of Bcl-2 and p53 gene In vitro [244]
Human (A375) and murine (B16-F1) melanoma Induce antiproliferative effect and hyperploid progression through G0/G1 cell cycle arrest and In vitro [245]
breast cancer (MCF-7), lung cancer (A549), and colon cancer (HCT-116) Inhibit cell proliferation with IC50 value of 5.053 μg/mL, 5.382 μg/mL, and 6.728 μg/mL against the breast, colon, and lung cancer cell lines, respectively In vitro [246]
HCT116 (colon); MCF7 (breast), and HepG2 (liver) Inhibit cell proliferation with IC50 ranged 117.99 to 482.65 µg/mL In vitro [247]
Breast cancer (MCF-7) Antiproliferative effect through induction of apoptosis. In vitro [248]
Prostate cancer cell line (PC-3) Promote apoptosis via modulation of G0/G1 phase, pro-inflammatory cytokines, calcium ions secretion and downregulation of prostate-specific antigen. In vitro [249]
Gelam HCT 116 Colorectal Cancer Cells Inhibit cell proliferation with IC50 of 75 mg/mL and induce apoptosis In vitro [250]
Colon cancer (HCT 116) Inhibit cell proliferation with IC50 2.0% v/v after 72 incubation In vitro [251]
Human diploid fibroblast Attenuated radiation-induced cell death by promoting cell cycle progression and inhibiting apoptosis by downregulating ATM, p73, and p16 In vitro [252]
HT 29 colon cancer Inhibit cell proliferation with IC50 of 39.0 mg/mL by inducing apoptosis through DNA damage and suppressing inflammation via reduction in prostaglandin E2. In vitro [220]
HT29 Colon cancer Promote apoptosis via mTOR and Wnt/B-catenin pathway.
-downregulated the gene expressions of
Akt, mTOR, Raptor, Rictor, β-catenin, Gsk3β, Tcf4 and cyclin D1 while cytochrome C and caspase 3 genes were
shown to be upregulated
In vitro [253]
HT29 colon cancer Induce apoptosis by upregulating early pro-apoptotic proteins (caspase 9 and IκB) and downregulating cancer-related genes (KRAS, ERK, AKT, Bcl-xL, NFkB (p65)) In vitro [254]
Pineapple HT 29 colon cancer Inhibit cell proliferation with IC50 of 85.5 mg/mL by inducing apoptosis through DNA damage and suppressing inflammation via reduction in prostaglandin E2. In vitro [220]
Kelulut Cervical cancer (HeLa) Inhibit cell proliferation with IC50 of 75.76 mg/mL) In vitro [255]
Lung cancer (A549) Inhibit cell proliferation at IC50 of 0.62% v/v by inducing cell cycle arrest at G2/M phase In vitro [256]
Sprague
Dawley rats
possessed chemo-preventive properties in rats induced with colorectal cancer and it was found to be not toxic to rats. In vivo [257]
Tualang Sprague
Dawley rats
Tualang honey ameliorated breast cancer by increasing the susceptibility of proapoptotic proteins; apoptotic protease activating factor-1 (Apaf-1) interferon-gamma (IFN-γ) interferon gamma receptor-1 (IFNGR1) tumor protein P53 (p53) and decreased the expression of anti-apoptotic proteins; tumour necrosis factor alpha (TNF-α), cyclooxygenase-2 (COX-2) and B-cell lymphoma-extra-large (Bcl-xL). In vivo [258]
Sprague
Dawley rats
Tualang Honey alleviated breast cancers in rats by reducing cancer cell growth and enhanced histological grading. In vivo [259]
Sprague
Dawley rats
Tualang honey showed chemo-preventive properties in oral squamous cell carcinoma-induced rats by suppressing cancer cell proliferation and activity and preserving cellular adhesion. In vivo [260]
Sprague
Dawley rats
Tualang Honey alleviated breast carcinogenesis by modulating haematologic, oestrogenic and apoptotic activities in the breast cancer animal model. In vivo [261]
Breast cancer (MCF-7 & MDA-MB-231) Tualang honey promoted apoptotic cell death induced by tamoxifen in breast cancer cell lines. In vitro [262]
Breast cancer (MCF-7 & MDA-MB-231) Tualang honey demonstrated cytotoxic and apoptotic activities against human breast cancer cell lines with the mitochondrial apoptotic pathway’s involvement. Activates caspase-3/7 and -9. In vitro [219]
Breast cancer (MCF-7) Tualang honey was found to be cytotoxic to breast cancer cell line (MCF-7) but protected non-tumorigenic epithelial breast cell line (MCF-10A) from the toxic effects of tamoxifen active metabolite 4-hydroxytamoxifen. In vitro [263]
Cervical cancer (HeLa) Tualang honey demonstrated cytotoxic and apoptotic activities against human cervical cancer cell lines with the mitochondrial apoptotic pathway’s involvement. Activates caspase-3/7 and -9. In vitro [219]
Oral squamous cell carcinomas (CRL-1623) Tualang honey showed an anti-proliferative effect on oral squamous cell carcinoma and osteosarcoma cell lines by inducing early apoptosis. In vitro [264]
Human Osteosarcomas (CRL-1543)
Acute and chronic myeloid leukaemia (K562 and MV4-11) Tualang honey demonstrated apoptosis-inducing ability for acute and chronic myeloid leukaemia (K562 and MV4-11) cell lines. In vitro [265]
Mouse keratinocyte (PAM212) Tualang honey protected keratinocytes from ultraviolet radiation-induced inflammation and DNA damage via modulation in early biomarkers of photocarcinogenesis. In vitro [266]
Human Keloid fibroblasts (pKHDF) The methanolic honey extraction has an antiproliferative effect on keloid fibroblasts at 50%, 25%, 12.50% and 6.25% of concentration. In vitro [267]
Lung cancer (A549 and H23) TH inhibited the proliferation of ADC cells in a dose- and time-dependent manner through cell cycle arrest at the G2/M phase. TH induces apoptosis through both intrinsic and extrinsic pathways. In vitro [268]
Lung cancer (A549 and H23) TH exerts anticancer activity through modulation of pertinent cancer-related proteins associated with cell proliferation, apoptosis, and angiogenesis, such as HRAS, HSPB1, TUBA1C, PCNA, ELAVL1, and H3F3A. In vitro [269]
Lung cancer (A549) TH promote apoptosis of A549 cells through alteration
of the PI3K/AKT signaling pathway-related proteins.
In vitro [270]
Head and neck cancer Tualang honey improved cancer-related fatigue and quality of life of patients with head and neck cancer post-chemotherapy or radiotherapy. Human study [271]
Breast cancer Combination of Tualang honey and anastrozole showed more improvement in decreasing breast background parenchymal enhancement in patients with breast cancer than anastrozole alone. Human study [272]